0.84
Schlusskurs vom Vortag:
$0.95
Offen:
$0.968
24-Stunden-Volumen:
74,595
Relative Volume:
0.58
Marktkapitalisierung:
$2.26M
Einnahmen:
$819.00K
Nettoeinkommen (Verlust:
$-17.70M
KGV:
-0.0663
EPS:
-12.6647
Netto-Cashflow:
$-8.45M
1W Leistung:
-21.50%
1M Leistung:
+1.20%
6M Leistung:
-62.16%
1J Leistung:
-86.45%
Catheter Precision Inc. Stock (VTAK) Company Profile
Firmenname
Catheter Precision Inc.
Sektor
Branche
Telefon
973 691 2000
Adresse
1670 Highway 160 West, Suite 205, Fort Mill
Compare VTAK vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
VTAK
Catheter Precision Inc.
|
0.84 | 2.26M | 819.00K | -17.70M | -8.45M | -12.66 |
|
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Catheter Precision Inc. Stock (VTAK) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-08-13 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2018-11-02 | Eingeleitet | Maxim Group | Buy |
Catheter Precision Inc. Aktie (VTAK) Neueste Nachrichten
Catheter Precision Inc (VTAK) Institutional Confidence - TradingKey
Volato Group closes $2.21 million private placement of common stock By Investing.com - Investing.com South Africa
Catheter Precision Inc (VTAK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Catheter Precision Inc (VTAK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Catheter Precision Inc (VTAK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Catheter Precision Inc (VTAK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Volato Group, Inc. announced that it has received $2.21 million in funding from Catheter Precision, Inc. - marketscreener.com
Catheter Precision Inc (VTAK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Catheter Precision Inc (VTAK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Catheter Precision Inc (VTAK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Catheter Precision Inc (VTAK) Valuation: PE, PB & Fair Value Analysis - TradingKey
Volato ends M2i merger agreement, gains new investors - Private Jet Card Comparisons
VTAK Q1 2025 Earnings: EPS Misses Estimates Significantly, Revenue Not ReportedCFO Commentary Report - newsline.com
FLYTE EXPANDS STRATEGIC RELATIONSHIP WITH VOLATO BY JOINING VAUNT PLATFORM - marketscreener.com
Empty private jet seats go on sale as Flyte plugs into Vaunt - Stock Titan
Private flights aim at 2026 World Cup traffic in Northeast - Stock Titan
Flyte Acquires 7.5% Stake in Volato to Expand Aviation Technology Ecosystem - citybiz
Catheter Precision's Flyte Acquires 7.5% Stake in Volato - marketscreener.com
Catheter Precision subsidiary invests in Volato Group By Investing.com - Investing.com South Africa
Flyte backs Volato with 7.5% stake, eyeing private aviation tie-ups - Stock Titan
Catheter Precision Makes Strategic Investment in Volato Group - TipRanks
Volato secures $2.2M investment led by Catheter Precision By Investing.com - Investing.com South Africa
Volato Group, Inc. and Catheter Precision, Inc. Enter Registration Rights Agreement for Common Stock Offering - Minichart
Catheter Precision (NYSE: VTAK) to buy $1M stake in Volato stock - Stock Titan
Volato (NYSE American: SOAR) gets $2.2M AI-focused strategic investment - Stock Titan
Volato Group, Inc. announced that it expects to receive $2.21 million in funding from Catheter Precision, Inc. - marketscreener.com
VTAK Stock Chart | CATHETER PRECISION INC (NYSEARCA:VTAK) - ChartMill
Belmont Stakes weekend to see private shuttle flight surge - Stock Titan
FLYTE ACTIVATES HIGH-FREQUENCY BELMONT STAKES FLIGHT PROGRAM, DEPLOYING FLEET TO CAPTURE TRIPLE CROWN DEMAND - Yahoo Finance
VTAK Stock Price, Quote & Chart | CATHETER PRECISION INC (NYSEARCA:VTAK) - ChartMill
VTAK Q1 2025 Earnings: Significant EPS Miss Amid Operational ChallengesEarnings Call Transcript - newsline.com
Catheter Precision Inc. (VTAK) Q1 2025 Earnings: Deep EPS Miss With No Revenue, Stock SlidesGrowth Acceleration Report - newsline.com
VTAK Q1 2025 Earnings: Wider-than-Expected Loss Sends Stock LowerStrong Earnings Momentum - The Legal Advocate
VTAK Q1 2025 Earnings: Wider Loss Than Expected Amid No Revenue GenerationEarnings Yield Analysis - The Legal Advocate
VTAK Q1 2025 Earnings: EPS Miss Widens as Revenue Remains UnreportedProfit Margin Analysis - The Legal Advocate
Catheter Precision Inc. (VTAK) Q1 2025 Earnings: Significant EPS Miss and No Revenue ReportedQuarterly Earnings - The Legal Advocate
Catheter Precision Company Profile & Introduction - Moomoo
Catheter Precision (VTAK) Q1 2025 Earnings: Significant EPS Miss as Stock Rises Amid Strategic Progress - Newser
Catheter Precision Inc. (VTAK) Gains 5.7% as Micro-Cap Stock Tests Resistance Near $0.88Volatility Breakout Picks - The Legal Advocate
Catheter Precision reports net loss of USD 1.7M in Q1 2026 - Medical Buyer
FLYTE ACTIVATES HIGH-FREQUENCY MEMORIAL DAY WEEKEND FLIGHT NETWORK TO CAPTURE SURGING NORTHEAST DEMAND - Yahoo Finance
Catheter Precision, Inc. (VTAK) Q1 2026 10-Q Report: Financials, Warrants, and Segment Details - Minichart
Catheter Precision (NYSE: VTAK) triples Q1 revenue and adds Flyte aviation - Stock Titan
Catheter Precision reports 200% revenue growth in Q1 2026 By Investing.com - Investing.com Nigeria
Catheter Precision reports 200% revenue growth in Q1 2026 - Investing.com
Catheter Precision Announces Brief 10-Q Filing Delay - TipRanks
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION - marketscreener.com
Medical device firm’s Q1 sales jump 200% after Flyte jet deal - Stock Titan
Catheter Precision, Inc. 1Q 2026: Revenue $432K, EPS ($1.39) — 10-Q Summary - TradingView
Catheter Precision: Revenue rose with FLYTE acquisition, but liquidity and dilution risks remain high - TradingView
Catheter Precision, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Finanzdaten der Catheter Precision Inc.-Aktie (VTAK)
Umsatz
Nettogewinn
Free Cashflow
ENV
Kapitalisierung:
|
Volumen (24h):